A phase I randomized, placebo-controlled, safety and efficacy study of a botulinum toxin type A topical gel for treatment of lateral canthal lines

被引：0
|
作者：
Garcia-Murray, Enrique [1 ]
Salcido-Calzadilla, Hector [1 ]
Waugh, Jacob [2 ]
机构：
[1] Hosp Santa Monica, Mexico City, DF, Mexico
[2] Revance Therapeut, Mountain View, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB32 / AB32
页数：1
相关论文
共 50 条
  • [41] Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study
    Evers, S
    Vollmer-Haase, J
    Schwaag, S
    Rahmann, A
    Husstedt, IW
    Frese, A
    CEPHALALGIA, 2004, 24 (10) : 838 - 843
  • [42] Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type a in subjects with crow's feet
    Lowe, NJ
    Ascher, B
    Heckmann, M
    Kumar, C
    Fraczek, S
    Eadie, N
    DERMATOLOGIC SURGERY, 2005, 31 (03) : 257 - 262
  • [43] Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-blind, Multicenter, Placebo-Controlled Phase 3 Study
    Mueller, Daniel S.
    Prinz, Valentina
    Adelglass, Jeffrey
    Cox, Sue Ellen
    Gold, Michael H.
    Kaufman-Janette, Joely
    Nestor, Mark S.
    Taylor, Susan
    Frank, Konstantin
    AESTHETIC SURGERY JOURNAL, 2022, 42 (06) : 677 - 688
  • [44] Botulinum toxin type A prophylactic treatment of episodic migraine: A randomized, double-blind, placebo-controlled exploratory study
    Aurora, Sheena K.
    Gawel, Marek
    Brandes, Jan L.
    Pokta, Suriani
    VanDenburgh, Amanda M.
    HEADACHE, 2007, 47 (04): : 486 - 499
  • [45] Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study
    Zirovich, Milena D.
    Pangarkar, Sanjog S.
    Manh, Christina
    Chen, Lucia
    Vangala, Sitaram
    Elashoff, David A.
    Izuchukwu, Ifeoma Stella
    MILITARY MEDICINE, 2021, 186 (5-6) : 493 - 499
  • [46] Treatment of Lateral Canthal Lines With RelabotulinumtoxinA, an Investigational Liquid Botulinum Toxin: Clinical Efficacy and Safety Results From the READY-2 Phase 3 Trial
    Ablon, Glynis
    Bank, David
    Kontis, Theda
    Ibrahim, Sherrif F.
    Palm, Melanie
    Cox, Sue Ellen
    Rivers, Jason K.
    Grunebaum, Lisa
    Goldman, Mitchel P.
    Humphrey, Shannon
    Lin, Xiaoming
    Nabhani, Schafiq
    Coquis-Knezek, Sarah
    TOXICON, 2024, 237 : 1 - 1
  • [47] A prospective, placebo-controlled, randomized, parallel group study of botulinum toxin type a for the treatment of mild to moderate platysmal bands
    Brandt, FS
    Boker, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P76 - P76
  • [48] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE USE OF BOTULINUM TOXIN TYPE-A IN THE TREATMENT OF SPASTICITY
    OBRIEN, CF
    SIMPSON, DM
    ALEXANDER, DN
    TAGLIATI, M
    ASWAD, AS
    GIBSON, J
    MONAGHAN, EP
    NEUROLOGY, 1995, 45 (04) : A329 - A329
  • [49] A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines
    Kamand Hedayat
    Amir H. Ehsani
    Aesthetic Plastic Surgery, 2024, 48 : 324 - 332
  • [50] A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines
    Hedayat, Kamand
    Ehsani, Amir H.
    AESTHETIC PLASTIC SURGERY, 2024, 48 (03) : 324 - 332
12345